PA
LILAK icon

PharVision Advisers’s Liberty Latin America Class C LILAK Stock Holding History

PharVision Advisers’s Portfolio LILAK Stock Details LILAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-32,568
Closed -$221K – 402
2025
Q4 		$221K Buy
+32,568
New +$244K 0.11% 476

Other funds holding LILAK

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SCP
Searchlight Capital Partners New York $109M AUM 43.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
QCI
Quaker Capital Investments Mount Lebanon, Pennsylvania $409M AUM 61.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PharVision Advisers's LILAK Position: Q1 2026 in Review

PharVision Advisers sold out of Liberty Latin America Class C (LILAK) in Q1 2026, closing a stake of 32,568 shares — an estimated $221K sold.

PharVision Advisers first reported a position in LILAK in Q4 2025 and held it in 1 quarter. The position peaked at $221K in Q4 2025. 205 funds tracked by Wall St. Rank hold LILAK as of Q1 2026.

  • PharVision Advisers reported no remaining Liberty Latin America Class C position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 32,568 Liberty Latin America Class C shares in Q1 2026, an estimated $221K.
  • PharVision Advisers first reported a position in Liberty Latin America Class C in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's Liberty Latin America Class C position peaked at $221K in Q4 2025.
  • 205 funds tracked by Wall St. Rank held Liberty Latin America Class C as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.